The following table shows the list of Horizon 2020 projects developed by "JULIUS CLINICAL RESEARCH BV". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | CONVINCE | H2020-EU.3.1.3. | participant | 2˙256˙001.00 | 2018-01-01 | 815 |
2 | HIT-CF | H2020-EU.3.1.3. | participant | 2˙703˙152.00 | 2018-01-01 | 974 |
3 | PREFERABLE | H2020-EU.3.1.3. | participant | 724˙040.00 | 2019-01-01 | 278 |
4 | Trials@Home | H2020-EU.3.1.7. | participant | 2˙788˙815.00 | 2019-09-01 | 307 |
totale | 8˙472˙008.00 |
This organization collaborated with partners in 17 countries.
Within the project CONVINCE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | FMC | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (PRC) |
participant | DE | B Braun Avitum | B.Braun Avitum AG (PRC) |
participant | SE | Diaverum | DIAVERUM SWEDEN AB (PRC) |
participant | UK | RFH | ROYAL FREE LONDON NHS FOUNDATION TRUST (REC) |
participant | IT | UBA | UNIVERSITA DEGLI STUDI DI BARI ALDO MORO (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project HIT-CF this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | US | Flatley | FLATLEY DISCOVERY LAB LLC (OTH) |
participant | NL | HUB | STICHTING HUBRECHT ORGANOID TECHNOLOGY (OTH) |
participant | DK | ECFS | EUROPEAN CYSTIC FIBROSIS SOCIETY (OTH) |
participant | BE | PATERGRUS BVBA | PATERGRUS BVBA (PRC) |
participant | DE | CFE | CYSTIC FIBROSIS EUROPE EV (OTH) |
participant | BE | GLPG | GALAPAGOS (PRC) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project PREFERABLE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | AU | Australian Catholic University Ltd | AUSTRALIAN CATHOLIC UNIVERSITY LIMITED (OTH) |
participant | ES | ONK | FUNDACION ONKOLOGIKOA FUNDAZIOA (REC) |
participant | IT | ED | EUROPA DONNA THE EUROPEAN BREAST CANCER COALITION (OTH) |
participant | DE | NURO | NUROGAMES GMBH (PRC) |
participant | DE | DSHS KOLN | DEUTSCHE SPORTHOCHSCHULE KOLN (HES) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | PL | MUG | GDANSKI UNIWERSYTET MEDYCZNY (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | NL | NKI | STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (REC) |
participant | DE | DKFZ | DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (REC) |
Within the project Trials@Home this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | IQVIA | IQVIA RDS FRANCE (PRC) |
participant | BE | Covance | COVANCE CLINICAL AND PERIAPPROVAL SERVICES (PRC) |
participant | UK | MRN | MEDICAL RESEARCH NETWORK LIMITED (PRC) |
participant | UK | eClinicalHealth | ECLINICALHEALTH LTD (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | NL | UPPMD | STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Allergan | ALLERGAN LIMITED (PRC) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | CH | Medtronic | MEDTRONIC INTERNATIONAL TRADING SARL (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | Lygature | STICHTING LYGATURE (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI Pharma | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | AT | JOANNEUM | FH JOANNEUM GESELLSCHAFT MBH (HES) |
participant | CH | Novartis | NOVARTIS PHARMA AG (PRC) |
participant | DK | SDU | SYDDANSK UNIVERSITET (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | BE | IDF Europe | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UU | UNIVERSITEIT UTRECHT (HES) |